ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1747

Dissecting the Role of Single Complement Deficiencies in a Novel Model for Apoptotic Cell-Induced Lupus

Lucrezia Colonna1, Clayton J. Sontheimer2, Lena M. Tanaka3, Kelly L. Hudkins4, Charles E. Alpers4, Keith B. Elkon1 and YuFeng Peng3, 1Department of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, 2Pediatric Rheumatology, University of Washington, Seattle, WA, 3Division of Rheumatology, University of Washington, Seattle, WA, 4Pathology, University of Washington, Seattle, WA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Apoptosis, C1q, complement and nephritis, Lupus

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Lupus Erythematosus – Animal Models - Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The role of complement in Systemic Lupus Erythematosus (SLE) is complex as complement deficiencies in early components of the classical pathway cause lupus with high penetrance, yet terminal complement activation at the level of the glomeruli causes kidney inflammation and damage in SLE. Aberrant accumulation or processing of dying cells that expose nucleosomes is thought to stimulate the production of lupus autoantibodies. To determine the relative contributions of excess dying cells, complement and autoantibodies, we created novel genetic models of lupus that contained one or more of these abnormalities, all on the C57BL/6 background.

Methods: Bicongenic mice were created by crossing mice deficient in the apoptotic cell (AC) opsonin, MFG-E8 (that accumulates AC in the germinal centers of the spleen), to sle1 mice (that produce autoantibodies to chromatin). These mice were then backcrossed to either C1q or C3 KO mice to create triple mutants. Anti-chromatin and anti-ds-DNA autoantibodies were measured by ELISA assay (n=20-30 per group). Autoantibodies specificities were determined on pooled sera (n=15-20 per strain) with the Autoantigen Microarray Super Panel (UT Southwestern Microarray Core). AC accumulation in the spleen and kidneys was detected by TUNEL staining (Roche). Kidney damage was evaluated by blood urea nitrogen (Amplite, AAT Bioquest), immuno-fluorescence for complement C3 (MP Biomedicals) and IgG2c (Jackson Immunoresearch), PAS staining and electron microscopy (E/M) (University of Washington Histology and Specialized Pathology Services).

Results:  sle1.MFG-E8 double mutant mice had significantly higher anti-DNA autoantibodies compared to sle1 mice alone (P<0.001). When sle1.MFG-E8 mice were crossed to C1q or C3 KO to create triple mutant mice, anti-chromatin and anti-DNA autoantibodies increased further (triple mutants compared to double mutants; p<0.05). In addition, when these strains were compared on an autoantigen array, the triple mutants demonstrated a significant broadening in antigenic specificity to include aggrecan, collagens, alpha-actinin, and others. Both triple mutant mouse strains showed AC accumulation in the kidneys and developed severe glomerulonephritis as determined by PAS staining. E/M analysis confirmed leukocyte infiltration and electron dense deposits near podocytes with podocyte destruction, as well as extensive tubular damage. Immunofluorescence analysis C1q triple mutants had abundant C3 deposition in the glomeruli, likely via activation of the alternative pathway, F4/80+ cell infiltrates in the interstitial and periglomerular space, and very prominent IgG2c deposits.

Conclusion: These studies reveal a stepwise contribution of all three elements studied here to lupus-like disease, and indicate that defective clearance of dying cells coupled with autoantibody production and impaired early complement function leads to a severe glomerulonephritis. Whereas it is likely that C3 activation contributed to nephritis in triple mutants lacking C1q, triple mutants lacking C3 also showed broadening of the autoantibody repertoire and developed intense nephritis suggesting that IgG FcgR engagement is sufficient to result in severe kidney damage.


Disclosure: L. Colonna, None; C. J. Sontheimer, None; L. M. Tanaka, None; K. L. Hudkins, None; C. E. Alpers, None; K. B. Elkon, None; Y. Peng, None.

To cite this abstract in AMA style:

Colonna L, Sontheimer CJ, Tanaka LM, Hudkins KL, Alpers CE, Elkon KB, Peng Y. Dissecting the Role of Single Complement Deficiencies in a Novel Model for Apoptotic Cell-Induced Lupus [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/dissecting-the-role-of-single-complement-deficiencies-in-a-novel-model-for-apoptotic-cell-induced-lupus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dissecting-the-role-of-single-complement-deficiencies-in-a-novel-model-for-apoptotic-cell-induced-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology